- Patients
- Clinical Research
- Find a clinical trial
- CA071-1000
Prostate Cancer
CA071-1000
A Phase 3, Two-part, Randomized, Open-label, Adaptive Study Comparing BMS-986365 versus a Second Androgen Receptor Pathway Inhibitor (ARPI), in Participants with Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Trial overview
Medical Oncology
Prostate
Genitourinary (GU)
III
Registration number: NCT06764485
Campbelltown (Oncology)
38 Camden Road, Campbelltown, NSW, 2560, Australia

Clinical trials enquiries
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.